PL3258927T3 - Mimetyki białek obronnych gospodarza (hdp) do profilaktyki i/lub leczenia chorób zapalnych przewodu pokarmowego - Google Patents

Mimetyki białek obronnych gospodarza (hdp) do profilaktyki i/lub leczenia chorób zapalnych przewodu pokarmowego

Info

Publication number
PL3258927T3
PL3258927T3 PL16752799T PL16752799T PL3258927T3 PL 3258927 T3 PL3258927 T3 PL 3258927T3 PL 16752799 T PL16752799 T PL 16752799T PL 16752799 T PL16752799 T PL 16752799T PL 3258927 T3 PL3258927 T3 PL 3258927T3
Authority
PL
Poland
Prior art keywords
hdp
mimetics
prophylaxis
treatment
gastrointestinal tract
Prior art date
Application number
PL16752799T
Other languages
English (en)
Inventor
Krishna Menon
Original Assignee
Innovation Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Pharmaceuticals Inc. filed Critical Innovation Pharmaceuticals Inc.
Publication of PL3258927T3 publication Critical patent/PL3258927T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16752799T 2015-02-20 2016-02-09 Mimetyki białek obronnych gospodarza (hdp) do profilaktyki i/lub leczenia chorób zapalnych przewodu pokarmowego PL3258927T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562118950P 2015-02-20 2015-02-20
PCT/US2016/017061 WO2016133733A1 (en) 2015-02-20 2016-02-09 Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract
EP16752799.3A EP3258927B8 (en) 2015-02-20 2016-02-09 Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract

Publications (1)

Publication Number Publication Date
PL3258927T3 true PL3258927T3 (pl) 2021-11-08

Family

ID=56689106

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16752799T PL3258927T3 (pl) 2015-02-20 2016-02-09 Mimetyki białek obronnych gospodarza (hdp) do profilaktyki i/lub leczenia chorób zapalnych przewodu pokarmowego

Country Status (15)

Country Link
US (3) US20160243117A1 (pl)
EP (1) EP3258927B8 (pl)
JP (1) JP6047203B2 (pl)
CN (1) CN107613967A (pl)
AU (1) AU2016220373B2 (pl)
DK (1) DK3258927T3 (pl)
ES (1) ES2881429T3 (pl)
HR (1) HRP20211107T1 (pl)
HU (1) HUE055090T2 (pl)
LT (1) LT3258927T (pl)
PL (1) PL3258927T3 (pl)
PT (1) PT3258927T (pl)
RS (1) RS62249B1 (pl)
SI (1) SI3258927T1 (pl)
WO (1) WO2016133733A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
DK2709619T3 (en) 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
KR20180080189A (ko) 2015-09-01 2018-07-11 퍼스트 웨이브 바이오, 인코포레이티드 이상 염증 반응과 연관된 질환을 치료하기 위한 방법 및 조성물
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629317B2 (en) * 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
JP5209302B2 (ja) * 2004-06-15 2013-06-12 ポリメディックス、インク. ポリカチオン化合物とその使用
US8017576B2 (en) * 2005-05-10 2011-09-13 The University Of Chicago Methods and compositions to treat mucositis
US20090092574A1 (en) * 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US8278309B2 (en) * 2008-10-27 2012-10-02 Polymedix, Inc. Synthetic mimetics of host defense and uses thereof
DK2709619T3 (en) * 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS

Also Published As

Publication number Publication date
US20160243117A1 (en) 2016-08-25
DK3258927T3 (da) 2021-07-19
HUE055090T2 (hu) 2021-10-28
SI3258927T1 (sl) 2022-03-31
RS62249B1 (sr) 2021-09-30
EP3258927A1 (en) 2017-12-27
JP6047203B2 (ja) 2016-12-21
EP3258927B1 (en) 2021-06-09
ES2881429T3 (es) 2021-11-29
AU2016220373A1 (en) 2017-10-12
CN107613967A (zh) 2018-01-19
US11666571B2 (en) 2023-06-06
AU2016220373B2 (en) 2020-10-22
US20230310435A1 (en) 2023-10-05
EP3258927B8 (en) 2021-09-15
LT3258927T (lt) 2021-09-27
JP2016153386A (ja) 2016-08-25
PT3258927T (pt) 2021-07-22
WO2016133733A1 (en) 2016-08-25
HRP20211107T1 (hr) 2021-10-15
US20200368232A1 (en) 2020-11-26
EP3258927A4 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
ZA201807098B (en) Cannabionid and cannabis-based compositions and methods for the treatment of inflammatory conditions of the gastrointestinal tract
SI3258927T1 (sl) Mimetiki proteina za zaščito gostitelja (ang. Host Defense Protein - HDP)za profilakso in/ali zdravljenje bolezni gastrointestinalnega trakta
IL256630B (en) Combined separator and coagulator
PT3297628T (pt) Azasetron para uso no tratamento de perda auditiva
GB2554354B (en) Systems for adaptive treatment of disorders in the gastrointestinal tract
EP3348273B8 (en) Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
ZA201903893B (en) Treatment of respiratory tract diseases and infections with glutathione compositions
EP3428178A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
FI3197556T3 (fi) Koostumus allergisten oireiden ennalta ehkäisemiseksi ja/tai hoitamiseksi
EP3509614A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF LAFORA DISEASE
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
GB201515244D0 (en) Treatment of inflammatory disease or condition
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
EP3428179A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
IL257689A (en) Pharmacological preparations and methods for the treatment of diseases associated with hypoxia
WO2015113041A3 (en) Compositions and methods for treating autoimmune and inflammatory diseases
AU2018903823A0 (en) Compositions and methods of treatment of conditions of the gastrointestinal tract
EP3854402C0 (en) TREATMENT OR PREVENTION OF GRAFT-VERSE-HOST DISEASE
GB201809835D0 (en) Treatment of gastrointestinal disease
EP3616687C0 (en) PREPARATION FOR THE TREATMENT AND/OR PREVENTION OF INFECTIOUS AND INFLAMMATORY DISEASES
HK1250343A1 (zh) 用於治療聽力損失的司瓊類鈣調神經磷酸酶抑制劑
AU2015900887A0 (en) Treatment and detection of inflammatory disease
EP3270963A4 (en) Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
AU2015902358A0 (en) Treatment of inflammatory disease